
|Articles|March 22, 2021
Pharmacy Times: Week of March 22 Lineup
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.
Advertisement
This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week, including:
- A video interview with Dr. Mitchell Horwitz, principal investigator and professor of medicine at the Duke Cancer Institute, that discusses the results of a phase 3 study of omidubicel and were recently presented at the Transplantation & Cellular Therapy Meetings of the American Society of Transplantation and Cellular Therapy and Center for International Blood & Marrow Transplant Research meetings.
- Representatives from the Academy of Managed Care Pharmacy student chapter at Nova Southeastern University discuss the challenges of remote learning during the coronavirus disease 2019 pandemic.
- An article that examines the scale of COVID-19 vaccinations over the next several weeks and months. As millions more people become eligible for the COVID-19 vaccine, there needs to be concerted effort to leverage innovative technologies to provide better transparency, visibility, and predictability to the vaccine deployment initiatives.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
The Peptide Reclassification Everyone's Talking About: A Pharmacist's Take on What RFK Jr's Announcement Actually Means
2
Subcutaneous Isatuximab On-Body Injector Shows High Reliability, Favorable Safety Across Multiple Myeloma Trials
3
Real-World Use of Talazoparib Plus Enzalutamide and HR Testing Trends in Prostate Cancer
4
Alzheimer Updates, Stroke Breakthroughs, and the Case for Early Treatment
5




























































































































